Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy

Annals of Internal Medicine

Volumn 122, Issue 8, 1995, Pages 586-591

  Shindo, Michiko ^a   Arai, Ken ^a   Sokawa, Yoshihiro ^b   Okuno, Tadao ^a  

^a Akashi Municipal Hospital   (Japan)

^b KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; JAPAN; LIVER HISTOLOGY; PRIORITY JOURNAL; RECURRENT INFECTION;

EID: 0028919926     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-122-8-199504150-00005     Document Type: Article

References (24)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, et al. Treatment of chronic hepatitis C with recombinant interferon-alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med. 1989;321:1501-6.
2. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med. 1989; 321:1506-10.
3. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 1990;335:1-3.
4. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, et al. Detection of hepatitis C viral sequences in blood donations by nested polymerase chain reaction and prediction of infectivity. Lancet. 1990;335:1419-22.
5. Okamoto H, Okada Y, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from 5′-noncoding region. Jpn J Exp Med. 1990;60:215-22.
6. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, et al. Decrease in serum hepatitis C viral RNA in serum during α -interferon therapy for chronic hepatitis C. Ann Intern Med. 1991;115:700-4.
7. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology. 1993;104:877-83.
8. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim KS, Shieh YS, et al. Hepatitis C RNA in liver of chronic C patients before and after interferon alfa treatment. Gastroenterology. 1993;104:1472-7.
9. Davis GL, Lindsay K, Albrecht J, Bodenheimer HC, Balart LA, Perrillo RP, et al. Predictors of response to recombinant interferon-α treatment in patients with chronic hepatitis C. Hepatology. 1990;12: 905.
10. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, et al. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology. 1991;101:497-502.
11. Tsubota A, Chayama K, Ikeda Y, Yasuji A, Koida I, Saitoh S, et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology. 1994;19:1088-94.
12. Serfaty L, Giral P, Loria A, Andreani T, Legendre C, Poupon R. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol. 1994;21:12-7.
13. Camps J, Garcia-Granero M, Riezu-Boj JI, Larrea E, de Alava E, Civeira MP, et al. Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon. J Hepatol. 1994;21: 4-11.
14. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol. 1994;21:1-3.
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology. 1991;1:431-5.
16. Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest. 1991; 88:1058-60.
17. Shindo M, Di Bisceglie AM, Biswas R, Mihalik K, Feinstone SM. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis. 1992;166:424-7.
18. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9.
19. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 1990;60:167-77.
20. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989; 339:237-8.
21. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992;73:673-9.
22. Di Bisceglie AM, Hoofnagle JH, Krawczynski K. Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology. 1993; 105:858-62.
23. Kanai K, Kato M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon [Letter]. Lancet. 1992;339:1543.
24. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992;16:293-9.